The Best AI Stock to Own in the World Today is Trading for Just $25

“Titan of Tech” Bets Big on Tiny AI Company He’s made as much as 3,250,000% in just three years on companies like Facebook, Airbnb, and PayPal… But our research shows his latest investment could be his most successful venture yet.

Ilan Daskal Biography and Net Worth

CFO of Bio-Rad Laboratories

Ilan Daskal was appointed Executive Vice President and Chief Financial Officer, effective April 6, 2019. Prior to joining Bio-Rad, Mr. Daskal, was the Chief Financial Officer of Lumileds, a global leader in advanced lighting technology, from May 2017 to January 2019. From 2015 through 2016, Mr. Daskal held multiple short-term Chief Financial Officer roles with private and public companies including Aricent Inc., a global design and engineering company, Cepheid, a molecular diagnostic company, and SunEdison Inc., a renewable energy company. Prior to that, from 2008 to 2015, Mr. Daskal was the Executive Vice President and Chief Financial Officer at International Rectifier Corporation, a leader in power management semi-conductor technology that was publicly traded until it was acquired by Infineon Technologies in 2015. Mr. Daskal also currently serves on the Board of Directors of Natus Medical Incorporated, a publicly-traded provider of medical device solutions.

What is Ilan Daskal's net worth?: The estimated net worth of Ilan Daskal is at least $2,502.36 as of September 3rd, 2021. Mr. Daskal owns 9 shares of Bio-Rad Laboratories stock worth more than $2,502 as of April 24th. This net worth approximation does not reflect any other investments that Mr. Daskal may own. Learn More about Ilan Daskal's net worth.
How do I contact Ilan Daskal?: The corporate mailing address for Mr. Daskal and other Bio-Rad Laboratories executives is 1000 ALFRED NOBEL DRIVE, HERCULES CA, 94547. Bio-Rad Laboratories can also be reached via phone at (510) 724-7000 and via email at [email protected]. Learn More on Ilan Daskal's contact information.
Has Ilan Daskal been buying or selling shares of Bio-Rad Laboratories?: Ilan Daskal has not been actively trading shares of Bio-Rad Laboratories over the course of the past ninety days. Most recently, Ilan Daskal sold 270 shares of the business's stock in a transaction on Friday, September 3rd. The shares were sold at an average price of $820.06, for a transaction totalling $221,416.20. Following the completion of the sale, the chief financial officer now directly owns 9 shares of the company's stock, valued at $7,380.54. Learn More on Ilan Daskal's trading history.
Who are Bio-Rad Laboratories' active insiders?: Bio-Rad Laboratories' insider roster includes Michael Crowley (EVP), Ilan Daskal (CFO), Timothy Ernst (EVP), Ronald Hutton (VP), Giovanni Magni (EVP), Ajit Ramalingam (CAO), and Annette Tumolo (EVP). Learn More on Bio-Rad Laboratories' active insiders.
Are insiders buying or selling shares of Bio-Rad Laboratories?: In the last twelve months, insiders at the medical research company sold shares 7 times. They sold a total of 8,190 shares worth more than $2,870,551.60. The most recent insider tranaction occured on February, 27th when EVP Michael Crowley sold 3,000 shares worth more than $1,008,000.00. Insiders at Bio-Rad Laboratories own 17.5% of the company. Learn More about insider trades at Bio-Rad Laboratories.
Information on this page was last updated on 2/27/2024.

Ilan Daskal Insider Trading History at Bio-Rad Laboratories

Transaction Date	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction	Details
9/3/2021	Sell	270	$820.06	$221,416.20	9
8/4/2021	Sell	2,300	$751.84	$1,729,232.00

Ilan Daskal Buying and Selling Activity at Bio-Rad Laboratories

Bio-Rad Laboratories Company Overview

Bio-Rad Laboratories, Inc. manufactures and distributes life science research and clinical diagnostic products in the United States, Europe, Asia, Canada, and Latin America. It operates through two segments, Life Science and Clinical Diagnostics. The company develops, manufactures, and markets instruments, systems, reagents, and consumables to separate, purify, characterize, and quantitate biological materials such as cells, proteins, and nucleic acids for proteomics, genomics, biopharmaceutical production, cellular biology, and food safety markets. It also designs, manufactures, markets, and supports test systems, informatics systems, test kits, and specialized quality controls for hospitals, diagnostic reference, transfusion, and physician office laboratories. The company offers its products through its direct sales force, as well as through distributors, agents, brokers, and resellers. Bio-Rad Laboratories, Inc. was founded in 1952 and is headquartered in Hercules, California.

Today's Range

Now: $278.04

$277.36

$285.27

50 Day Range

MA: $327.31

$278.04

$351.99

2 Week Range

Now: $278.04

$261.59

$473.50

Volume

209,104 shs

Average Volume

203,730 shs

Market Capitalization

$7.93 billion

P/E Ratio

N/A

Dividend Yield

N/A

Beta

0.87

The Best AI Stock to Own in the World Today is Trading for Just $25

From Banyan Hill Publishing | Ad

See how you can invest alongside him